Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Epinephrine Market by Type (Epinephrine Auto-injector, Epinephrine Prefilled Syringe, Combination Epinephrine Products), By Application (Anaphylaxis, Cardiac Arrest, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Epinephrine Market by Type (Epinephrine Auto-injector, Epinephrine Prefilled Syringe, Combination Epinephrine Products), By Application (Anaphylaxis, Cardiac Arrest, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 131793 3300 Medical Devices & Consumables 377 245 Pages 4.5 (36)

Market Overview:

The global epinephrine market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of anaphylaxis, rising number of cardiac arrests, and growing demand for combination epinephrine products. However, the high cost of epinephrine products is expected to restrain the growth of this market during the forecast period. The global epinephrine market is segmented by type, application, and region. By type, the market is divided into Epinephrine Auto-injector (EAI), Epinephrine Prefilled Syringe (EPS), and Combination Epinephrine Products (CEP). EAI held a dominant position in 2017 and is projected to maintain its dominance during the forecast period owing to its ease-of-use and increased adoption among patients suffering from anaphylaxis. EPS are anticipated to witness significant growth during the forecast period due their low cost as compared with EAIs and CEPs. By application,the global epinephrinemarketis segmented into Anaphylaxis,, Cardiac Arrest,,and Others,. Anaphylaxis accounted for majority share in 2017 owingtoits high prevalence across all regions studied in this research study..

Global Epinephrine Industry Outlook

Product Definition:

Epinephrine is a hormone and neurotransmitter that is responsible for the "fight or flight" response. It increases heart rate, blood pressure, and breathing rate, and it also opens up airways in the lungs. Epinephrine is important for responding to emergencies because it helps prepare the body to deal with a stressful situation.

Epinephrine Auto-injector:

Epinephrine (Adrenaline) auto-injector is a device that enables the user to deliver an injection of epinephrine (adrenaline) on impulse. The Epinephrine Auto-Injector market is driven by factors such as increasing awareness among consumers regarding self-care, growing prevalence of life threatening allergic conditions and rising number of accidental injuries.

U.S Epinephrine Auto Injector Market, by Product Type 2014 - 2022 -> The U.

Epinephrine Prefilled Syringe:

Epinephrine (Adrenaline) is a colorless clear sterile solution used in the treatment of anaphylaxis which occurs due to rapid heart rate, weak pulse, and breathlessness. It works by opening airways, increasing blood flow to the lungs and accelerating the heart rate.

Application Insights:

Anaphylaxis was the leading application segment in terms of revenue share in 2017. Anaphylaxis is a severe allergic reaction that can lead to death within minutes without treatment. The incidence of anaphylaxis has increased significantly over the past few years and a high number of deaths are reported due to this condition every year. Epinephrine is widely used for the treatment of anaphylaxis as it works quickly than other treatments such as oxygen and antihistamines.

The cardiac arrest segment is expected to grow at fastest rate during forecast period owing to increasing cases of sudden cardiac arrest among children and adults across the globe, especially in developing countries like India, China etc., where most fatal heart attacks occur outside hospitals due to lack of proper healthcare facilities at home; these factors are likely drive market growth during forecast period (2018-2030).

Regional Analysis:

Europe dominated the global epinephrine market in 2017 owing to a rise in awareness about anaphylaxis and increasing incidence of food allergies. In addition, presence of regulatory bodies for the approval of products is also expected to drive regional growth. For instance, EMA has approved Mylan's EpiPen for marketing across Europe since it met the required standards.

Asia Pacific is expected to grow at a lucrative rate over the forecast period due to factors such as growing economy and improving healthcare infrastructure that leads to increased adoption of these auto-injectors & prefilled syringes among patients suffering from life-threatening allergic reactions & anaphylaxis.

Growth Factors:

  • Increasing incidence of anaphylaxis: The increasing incidence of anaphylaxis is one of the key growth drivers for the epinephrine market. Anaphylaxis is a serious, potentially life-threatening allergic reaction that can occur within minutes after exposure to an allergen. According to a study by Allergy UK, around 1 in 50 people in the UK suffer from anaphylaxis every year and this number is on the rise. This growing prevalence of allergies is expected to drive demand for epinephrine products in the coming years.
  • Growing awareness about self-injectable epinephrine devices: There has been a growing awareness among patients about self-injectable epinephrine devices in recent years. This has led to an increase in adoption rates of these devices, which is expected to drive market growth over the forecast period.
  • Rising prevalence of food allergies: The rising prevalence of food allergies across all age groups is another major factor driving market growth globally. According to a study by FAIR Health, Inc., food allergies account for nearly half (47%)of all reported cases involving adverse reactions resulting from ingestion or contact with foods during 2016–2017 period studied). This high incidence rate is expected to create significant demand for epinephrine products in coming years . 4) Technological advancements: The advent of novel technologies such as smart auto-injectors and wearable patches are likely to fuel market growth over the forecast

Scope Of The Report

Report Attributes

Report Details

Report Title

Epinephrine Market Research Report

By Type

Epinephrine Auto-injector, Epinephrine Prefilled Syringe, Combination Epinephrine Products

By Application

Anaphylaxis, Cardiac Arrest, Others

By Companies

Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, Amphastar, Emerade, Grand Pharma, Harvest Pharmaceuticals, Merit Pharmaceutical, Tianjin Jinyao Group

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Epinephrine Market Report Segments:

The global Epinephrine market is segmented on the basis of:


Epinephrine Auto-injector, Epinephrine Prefilled Syringe, Combination Epinephrine Products

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Anaphylaxis, Cardiac Arrest, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Mylan Inc
  2. Impax
  3. ALK Abello
  4. Lincoln Medical Ltd
  5. Pfizer
  6. Amphastar
  7. Emerade
  8. Grand Pharma
  9. Harvest Pharmaceuticals
  10. Merit Pharmaceutical
  11. Tianjin Jinyao Group

Global Epinephrine Market Overview

Highlights of The Epinephrine Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Epinephrine Auto-injector
    2. Epinephrine Prefilled Syringe
    3. Combination Epinephrine Products
  1. By Application:

    1. Anaphylaxis
    2. Cardiac Arrest
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Epinephrine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Epinephrine Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Epinephrine is a hormone that helps the body respond to emergencies by increasing heart rate, blood flow and respiration. It is also used to treat anaphylaxis, a life-threatening allergic reaction.

Some of the key players operating in the epinephrine market are Mylan Inc, Impax, ALK Abello, Lincoln Medical Ltd, Pfizer, Amphastar, Emerade, Grand Pharma, Harvest Pharmaceuticals, Merit Pharmaceutical, Tianjin Jinyao Group.

The epinephrine market is expected to register a CAGR of 5.5%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Epinephrine Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Epinephrine Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Epinephrine Market - Supply Chain
   4.5. Global Epinephrine Market Forecast
      4.5.1. Epinephrine Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Epinephrine Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Epinephrine Market Absolute $ Opportunity

5. Global Epinephrine Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Epinephrine Market Size and Volume Forecast by Type
      5.3.1. Epinephrine Auto-injector
      5.3.2. Epinephrine Prefilled Syringe
      5.3.3. Combination Epinephrine Products
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Epinephrine Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Epinephrine Market Size and Volume Forecast by Application
      6.3.1. Anaphylaxis
      6.3.2. Cardiac Arrest
      6.3.3. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Epinephrine Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Epinephrine Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Epinephrine Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Epinephrine Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Epinephrine Demand Share Forecast, 2019-2029

9. North America Epinephrine Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Epinephrine Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Epinephrine Market Size and Volume Forecast by Application
      9.4.1. Anaphylaxis
      9.4.2. Cardiac Arrest
      9.4.3. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Epinephrine Market Size and Volume Forecast by Type
      9.7.1. Epinephrine Auto-injector
      9.7.2. Epinephrine Prefilled Syringe
      9.7.3. Combination Epinephrine Products
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Epinephrine Demand Share Forecast, 2019-2029

10. Latin America Epinephrine Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Epinephrine Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Epinephrine Market Size and Volume Forecast by Application
      10.4.1. Anaphylaxis
      10.4.2. Cardiac Arrest
      10.4.3. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Epinephrine Market Size and Volume Forecast by Type
      10.7.1. Epinephrine Auto-injector
      10.7.2. Epinephrine Prefilled Syringe
      10.7.3. Combination Epinephrine Products
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Epinephrine Demand Share Forecast, 2019-2029

11. Europe Epinephrine Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Epinephrine Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Epinephrine Market Size and Volume Forecast by Application
      11.4.1. Anaphylaxis
      11.4.2. Cardiac Arrest
      11.4.3. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Epinephrine Market Size and Volume Forecast by Type
      11.7.1. Epinephrine Auto-injector
      11.7.2. Epinephrine Prefilled Syringe
      11.7.3. Combination Epinephrine Products
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Epinephrine Demand Share, 2019-2029

12. Asia Pacific Epinephrine Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Epinephrine Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Epinephrine Market Size and Volume Forecast by Application
      12.4.1. Anaphylaxis
      12.4.2. Cardiac Arrest
      12.4.3. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Epinephrine Market Size and Volume Forecast by Type
      12.7.1. Epinephrine Auto-injector
      12.7.2. Epinephrine Prefilled Syringe
      12.7.3. Combination Epinephrine Products
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Epinephrine Demand Share, 2019-2029

13. Middle East & Africa Epinephrine Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Epinephrine Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Epinephrine Market Size and Volume Forecast by Application
      13.4.1. Anaphylaxis
      13.4.2. Cardiac Arrest
      13.4.3. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Epinephrine Market Size and Volume Forecast by Type
      13.7.1. Epinephrine Auto-injector
      13.7.2. Epinephrine Prefilled Syringe
      13.7.3. Combination Epinephrine Products
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Epinephrine Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Epinephrine Market: Market Share Analysis
   14.2. Epinephrine Distributors and Customers
   14.3. Epinephrine Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Mylan Inc Overview Financials Developments Strategic Outlook
      14.4.2. Impax Overview Financials Developments Strategic Outlook
      14.4.3. ALK Abello Overview Financials Developments Strategic Outlook
      14.4.4. Lincoln Medical Ltd Overview Financials Developments Strategic Outlook
      14.4.5. Pfizer Overview Financials Developments Strategic Outlook
      14.4.6. Amphastar Overview Financials Developments Strategic Outlook
      14.4.7. Emerade Overview Financials Developments Strategic Outlook
      14.4.8. Grand Pharma Overview Financials Developments Strategic Outlook
      14.4.9. Harvest Pharmaceuticals Overview Financials Developments Strategic Outlook
      14.4.10. Merit Pharmaceutical Overview Financials Developments Strategic Outlook
      14.4.11. Tianjin Jinyao Group Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us